Exploring the Patient Journey: Let’s Talk About ILD and IPF

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Exploring the Patient Journey: Let’s Talk About ILD and IPF

Program Information
Exploring the Patient Journey: Let’s Talk About ILD and IPF
Join Dr. Caudle as she discusses IPF with physician, Dr. Flaherty, and patient ambassador, Mr. Cunningham.

Available credits: 0.50

Time to complete: 30 minutes

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This activity is no longer available for credit.

    This discussion highlights the challenges with IPF diagnosis, explains when to refer, analyzes the need for personalized medicine, and demonstrates how to keep patients on treatment. 

  • Learning Objectives

    • Use a multidisciplinary approach based on ATS/ERS guidelines for diagnosing IPF
    • Recognize signs and symptoms that may indicate IPF
    • Refer patients with suspected IPF to a specialist in a timely manner
    • Provide rationales for starting treatment
  • Target Audience

    This educational activity is intended for primary care providers.

  • Faculty Disclosure

    Kevin R. Flaherty, MD, MS, has consulted for Boehringer Ingelheim Pharmaceuticals, Inc., Roche/Genentech, Fibrogen, and Veracyte. He has also done contract research for Afferent, Boehringer Ingelheim Pharmaceuticals, Inc., and Roche/Genentech.

    Gary Cunningham has nothing to disclose. 

  • Accreditation and Credit Designation Statements

    The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The France Foundation designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Maintenance of Certification

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

  • Provider(s)/Educational Partner(s)

  • Commercial Support

    This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.

  • Terms of Use

    The France Foundation (TFF) requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

  • Method of Participation/How to Receive Credit

    1. Review the activity objectives and CME/CE information.
    2. Complete the CME/CE activity.
    3. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
    4. Complete the CME/CE evaluation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  • Disclaimer

    The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation assumes no liability for the information herein.

LIVE ON REACHMD RADIOBack to live radio


Programs 10/23/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.